Immersion oil is commonly referred to as pellucid oils having specific optional and viscosity features suitable for microscopy. Refractive index of immersion oil is closer as compared to that of glass and does not refract the light focused on to the item being examined. Hence, light beam is completely focused on to the object which is examined opposed to the beams of light scattering through air.
Global Defoamers Market is Expected to Grow at 4.8% by 2033. Defoamers, also known as antifoaming agents are chemicals that obstructs foam to develop during various industrial processes. They possess surface-active properties and do not dissolve in a foaming medium.
Sodium Chlorite is a white and odorless powder that is used to produce chlorine dioxide. This chlorine dioxide mainly finds application in textiles, bleaching, and pulp along with water purification. One of the main property of chlorine dioxide is its destruction capability of specific pathogenic bacteria while at the same time being useful for intestinal bacteria.
The American College of Obstetricians and Gynecologists states that around 5%-25% pregnant women experience postpartum depression in America. This growing prevalence primarily contribute to the lucrativeness of this market.
The global hypercalcemia treatment market will reach US$ 33,854.7 Mn by 2033 from US$ 13,628.9 Mn in 2021, growing at a CAGR of 10.7% during the forecast period from 2025 to 2033. Hypercalcemia is a condition characterized by elevated levels of serum calcium ranging above 2.6 mmol/L.
Anti-inflammatory therapeutics market expected to reach by US$ 186.1 Bn by 2033 with CAGR of 8.5% during the forecast period from 2025 to 2033. Biologics and immune selective anti-inflammatory derivatives (ImSAIDs) are the promising drugs classes playing major role in the market.
The global seborrheic keratosis (SK) treatment expected to reach US$ 1,320.8 Mn by 2026. Growing preference for cosmetic and aesthetic quotient and high prevalence of seborrheic keratosis are observed to be the key factors driving the seborrheic keratosis treatment market. This market is further characterized by the presence of a multitude of players operating in various treatment modules such as laser, cryosurgery, surgical removal etc. In addition, with promising topical candidates in the pipeline, the seborrheic keratosis treatment market will witness a boost in future growth.
Ultra-low temperature freezers (ULT freezers) are among the most crucial equipment used in healthcare sector to preserve biological samples, drugs, pathogens and others. ULT freezers are designed to operate between -460C to -860C. Thus, ultra-low temperature freezers have become highly popular in medical and R&D sectors to effectively preserve drugs, body organs and blood samples among others. Rising incidences of cancer and other infectious diseases is one of the prominent factors stimulating the market growth.
The incidence of radiation toxicity is on a rise with increase in treatment and diagnosis of various diseases using radiation therapy and nuclear medicine, thus driving the overall market growth. Cancer treatment predominantly utilizes radiation therapy to treat tumours and cancerous cells. Growing prevalence of cancer thus increases the rate of radiation therapy indicating growing risk of radiation toxicity.
The advent of the Internet has made it extremely easy to place order for goods online. This has resulted in an exponential rise in the volume of parcels and packages thereby creating the need for efficient solutions to sort these parcels in order to deliver them to the customers. The ability to correctly and efficiently sort a complete product range that too in a required timeframe without any manual intervention is often one of the greatest challenges faced by depots.
The drugs by therapeutic area include therapy for oncology, cardiovascular, central nervous system, infectious diseases, respiratory, and others. The therapeutic area represents the specific area of medicine where the drug is intended to be used, based on its mechanism of action and intended clinical use. One of the primary drivers of the drugs by therapeutic area market is the increasing prevalence of diseases worldwide. Chronic diseases such as cancer, cardiovascular diseases, and neurological disorders are a significant burden on healthcare systems globally. There is an urgent need for new and effective therapies to treat these diseases, which has led to the growth of the drugs in the therapeutic area market.
The revenues generated by the drugs in the therapeutic area market have been consistently high over the years. The global pharmaceutical market is expected to reach USD 1.5 trillion by 2023, with oncology being the leading therapeutic area. The increasing demand for new therapies, coupled with advancements in technology and an increasing focus on personalized medicine, is expected to drive the growth of the market in the coming years. One of the emerging trends in the drugs by therapeutic area market is the increasing use of precision medicine. Precision medicine involves tailoring medical treatments to individual patients based on their unique genetic and molecular profiles. The development of precision medicine requires the use of advanced diagnostic tools and drug discovery technologies, which have contributed to the growth of drugs in the therapeutic area market.
Another trend in the drugs by therapeutic area market is the increasing focus on biologics. Biologics are drugs that are produced from living cells and are used to treat a wide range of diseases, including cancer and autoimmune disorders. Biologics are more complex than traditional small-molecule drugs, and their development requires specialized manufacturing processes and clinical trial design. The increasing demand for biologics has contributed to the growth of the drugs by therapeutic area market. The increasing focus on rare diseases is also driving the growth of the drugs by therapeutic area market. Rare diseases are defined as diseases that affect fewer than 200,000 people in the United States. Although each rare disease affects a small number of people, there are over 7,000 rare diseases, which together affect millions of people worldwide. There is an urgent need for new therapies to treat rare diseases, which has led to the growth of drugs in the therapeutic area market.
The increasing use of combination therapies is driving the growth of the drugs by therapeutic area market. Combination therapies involve the use of two or more drugs to treat a disease. Combination therapies can improve patient outcomes by targeting multiple pathways involved in the disease process. The development of combination therapies requires the use of advanced drug discovery technologies and clinical trial design, which has contributed to the growth of the drugs by therapeutic area market. The increasing prevalence of diseases worldwide, advancements in technology, and the emerging trends in precision medicine, biologics, rare diseases, and combination therapies are expected to drive the growth of the drugs by therapeutic area market.
